Scarica l'app Stockscreener
88.50
0.18%
-0.24
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Ani Pharmaceuticals Inc Borsa (ANIP) Ultime notizie
Azenta, LifeStance Health Group, BioMarin Pharmaceutical, AMN Healthcare Services, and ANI Pharmaceuticals Stocks Trade Up, What You Need To Know - Yahoo Finance
ANI Pharmaceuticals Inc. Surpasses Analyst Target Price of $83.12 - AInvest
ANI Pharmaceuticals Reports Record Growth in Q2 2025 - TipRanks
ANI Pharmaceuticals, Inc. (NASDAQ:ANIP) Q2 2025 Earnings Call Transcript - Insider Monkey
What technical models suggest about ANI Pharmaceuticals Inc.’s comebackFree Trade Setups With AI Powered Filters - Newser
Truist Securities Adjusts ANI Pharmaceuticals Price Target to $77 From $65, Maintains Hold Rating - MarketScreener
Historical volatility pattern of ANI Pharmaceuticals Inc. visualizedSmart Entry Watchlist with Daily Analysis - Newser
Trend analysis for ANI Pharmaceuticals Inc. this weekFree Profit Target Stock Opportunity Monitor - Newser
How high can ANI Pharmaceuticals Inc. stock goFundamental + Technical Combined Watchlist - Newser
When is the best time to exit ANI Pharmaceuticals Inc.Real-Time Signal Tracking with Entry Level - Newser
ANI Pharmaceuticals, Inc. (NASDAQ:ANIP) Surges 25% Yet Its Low P/S Is No Reason For Excitement - simplywall.st
ANI Pharmaceuticals Second Quarter 2025 Earnings: Beats Expectations - Yahoo Finance
ANI Pharmaceuticals Q2 2025 Earnings Call Highlights: Record Revenue, Raised Guidance, and Strong Growth - AInvest
Should I buy ANI Pharmaceuticals Inc. stock before earningsFree Swing Setup With Technical Confirmation - Newser
ANI Pharmaceuticals: A High-Growth Biopharma Play with Rare Disease and Generics Synergy - AInvest
Is ANI Pharmaceuticals Inc. stock poised for growthLow Risk Stock Selection Strategy Guide - Newser
Assessing ANI Pharmaceuticals' (ANIP) Growth Trajectory in Rare Diseases and Generics Amid Strategic and Financial Headwinds - AInvest
ANI Pharmaceuticals raises 2025 guidance to $843M revenue and $7.35 EPS as Cortrophin Gel accelerates - MSN
Advanced analytics toolkit walkthrough for ANI Pharmaceuticals Inc.Free Buy Signal Based on Chart Analysis - Newser
ANI Pharmaceuticals Receives Buy Rating and Optimistic Price Target - timothysykes.com
ANI Pharmaceuticals, Inc. (NASDAQ:ANIP) Given Average Recommendation of “Buy” by Brokerages - Defense World
Will ANI Pharmaceuticals Inc. rebound enough to break evenFree Short Term Buy List With Stop Protection - Newser
ANI Pharma Stock Shoots Through The Roof On Friday: CEO’s Confidence On Trump Tariff Impact, Guidance Lift, Upbeat Q2 Among Key Factors - MSN
ANI Pharmaceuticals Inc. stock daily chart insightsFree Fundamental + Technical Hybrid Stock Tips - Newser
ANI Pharmaceuticals (NASDAQ:ANIP) Reaches New 52-Week High Following Earnings Beat - Defense World
ANI Pharmaceuticals Inc (ANIP) Q2 2025 Earnings Call Highlights: Record Revenue and Raised ... By GuruFocus - Investing.com Canada
Published on: 2025-08-09 00:38:02 - Newser
ANI Pharmaceuticals' Q2 2025: Unpacking Contradictions in Cortrophin Growth and Market Dynamics - AInvest
ANI Pharmaceuticals stock price target raised to $93 from $84 at H.C. Wainwright - Investing.com Canada
ANI: Q2 Earnings Snapshot - Norwalk Hour
Quantitative breakdown of ANI Pharmaceuticals Inc. recent moveFree Low Risk Buy Zone Opportunity Watch - Newser
Ani Pharmaceuticals shares rise 18.40% intraday after beating Q2 revenue and EPS estimates, raising FY forecast. - AInvest
ANI Pharmaceuticals price target raised to $93 from $84 at H.C. Wainwright - TipRanks
Why ANI Pharmaceuticals (ANIP) Stock Is Up Today - TradingView
ANI Pharmaceuticals Stock Surges After Buy Rating and Strong Price Target - StocksToTrade
ANI Pharmaceuticals Surges as Buy Rating Hits Market - timothysykes.com
ANI Pharmaceuticals Surges 19%: What's Fueling This Explosive Move? - AInvest
Earnings call transcript: ANI Pharmaceuticals Q2 2025 earnings beat forecasts By Investing.com - Investing.com Nigeria
Earnings call transcript: ANI Pharmaceuticals Q2 2025 earnings beat forecasts - Investing.com
Transcript : ANI Pharmaceuticals, Inc., Q2 2025 Earnings Call, Aug 08, 2025 - MarketScreener
ANI Pharmaceuticals Inc reports results for the quarter ended March 31Earnings Summary - TradingView
Ani Pharmaceuticals stock hits 52-week high at 77.86 USD By Investing.com - Investing.com Nigeria
ANI Pharmaceuticals reports Q2 adjusted EPS $1.80, consensus $1.42 - TipRanks
Cg Oncology (CGON) Q2 Loss Widens 93% - The Motley Fool
ANI Pharmaceuticals (ANIP) Q2 Earnings and Revenues Surpass Estimates - Yahoo Finance
ANI Pharmaceuticals Boosts FY25 Outlook; Stock Up 7%Update - Nasdaq
ANI Pharmaceuticals Q2 Adjusted Earnings, Revenue Rise; 2025 Guidance Raised - MarketScreener
ANI Pharmaceuticals Reports Record Second Quarter 2025 Financial Results - TradingView
ANI PHARMACEUTICALS INC SEC 10-Q Report - TradingView
ANI Pharmaceuticals’s (NASDAQ:ANIP) Q2: Strong Sales, Stock Soars - Yahoo Finance
ANI Pharmaceuticals beats Q2 revenue, EPS beats estimates and raises FY forecast - MarketScreener
(ANIP) ANI Pharmaceuticals Expects 2025 Revenue Range $818M$843M, vs. FactSet Est of $791.5M - MarketScreener
Record Q4 net revenues up 53.1% YoY to $211.4mln, raises FY23 guidance. - AInvest
(ANIP) ANI Pharmaceuticals Expects Full-Year 2025 Adjusted EPS Range $6.98$7.35, vs. FactSet Est of $6.53 - MarketScreener
Earnings Flash (ANIP) ANI Pharmaceuticals, Inc. Reports Q2 Revenue $211.4M, vs. FactSet Est of $190.1M - MarketScreener
ANI Pharmaceuticals Reports Record Second Quarter 2025 Financial Results and Raises 2025 Guidance - GlobeNewswire
Earnings Flash (ANIP) ANI Pharmaceuticals, Inc. Posts Q2 Adjusted EPS $1.80 per Share, vs. FactSet Est of $1.41 - MarketScreener
ANI Pharma Stock Shoots Through The Roof On Friday: CEO's Confidence On Trump Tariff Impact, Guidance Lift, Upbeat Q2 Among Key Factors - Menafn
How ANI Pharmaceuticals Inc. stock performs during market volatilityRSI Divergence and Support Breakout Analysis - Newser
Earnings Preview For ANI Pharmaceuticals - 富途牛牛
ANI Pharmaceuticals, Inc. (NASDAQ:ANIP) Shares Acquired by Envestnet Asset Management Inc. - Defense World
ANI Pharmaceuticals (ANIP) Projected to Post Earnings on Friday - Defense World
ANI Pharmaceuticals (ANIP) Q2 Earnings: What To Expect - MSN
ANI Pharmaceuticals Q2 Earnings: What to Expect and How to Prepare - AInvest
1.47%
0.07%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):